Minnetronix Names Anthony Millar Vice President of Operations

Saint Paul, MN Aug 29, 2016 – Minnetronix, Inc., a leading medical technology and innovation company, announced that Anthony Millar has joined the company as Vice President of Operations. Millar has more than 15 years of healthcare industry experience in manufacturing, new product development, supply chain, quality assurance and compliance.
Millar will play an integral role on Minnetronix’ leadership team, developing strategies to grow and expand capabilities for the company’s manufacturing operations. He will also oversee Minnetronix’ highly experienced production teams in the manufacturing of technologies and devices for the company and its customers.
“Anthony has a wealth of industry experience and proven leadership in device manufacturing,” said Jeremy Maniak, Minnetronix Chief Operating Officer. “We are pleased to welcome him to Minnetronix and know he will be a great asset to the company as we continue to grow and expand our operations.”
Millar joins Minnetronix from Greatbatch Medical, where he led manufacturing operations for multiple sites as Executive Director of Operations. Prior to Greatbatch, Millar served as the Director of Operations for MedImmune, a division of AztraZeneca. His experience also includes multiple manufacturing and engineering management positions at Boston Scientific and production and finance positions at Guidant. Before his career in the healthcare industry, Millar served as an officer in the United States Marine Corps.
“I am excited to join Minnetronix at such a dynamic time in the company’s history,” said Millar. “Minnetronix has a very promising future and I look forward to contributing to the company’s success.”
Millar is a Six Sigma Black Belt with significant experience in the application of Lean and Six Sigma methodologies. He earned his Bachelor of Arts in Political Science from the University of Illinois. He was also awarded a Master of Science in Business Administration from Boston University and is currently pursuing a Master of Engineering Management from Penn State.
About Minnetronix
Minnetronix is a medical technology and innovation company with deep expertise in electronic and electromechanical devices. Founded in 1996, the company creates new technologies and therapies that solve unmet clinical and business needs for patients and medical device companies. Minnetronix is FDA Registered and ISO 13485 Certified.

CSafe Announces Biopharmaceutical Cold Chain Sales Director for Southeast USA

Dayton, OH Aug 22, 2016 – CSafe Global continues to strategically expand the team of Sales Directors supporting superior cold chain solutions to global Life Science companies.
CSafe Global announced the appointment of Abigail French as the company’s newest Director of Strategic Life Science Sales. Mrs. French, who is based in North Carolina, will be responsible for contributing to CSafe’s overall business growth while she consults with the regions biopharma, medical device, and partner companies. With extensive experience in biotech, pharmaceutical, medical device, and temperature control markets, Abigail will be an integral participant in the company’s global market penetration strategy.
Before joining CSafe, Abigail held top performing sales positions within LABRepCo, Covidien/Medtronic, and Aventis. “I am extremely impressed with the CSafe Global portfolio of cold chain solutions and its unrivalled value proposition”, remarked Abigail. “It’s an exciting time. CSafe is uniquely positioned as the only global manufacturer with a full suite of both active and passive temperature management solutions. I’ve been in this industry a long time and to join a company that’s completely committed seeking the best solutions without limiting their options to one particular technology is exciting!”
CSafe Global has become the world leader in temperature-controlled containers for sensitive pharma and medical products and this new appointment is part of the company’s ambitious expansion plans. With its principal biopharma market continuing to grow continuing to grow significantly, the company is investing heavily in expanding its international footprint and in pioneering innovative, market-leading solutions.
Commenting on the new appointment, Nadine Siqueland, Vice President of Global Sales said: “Abigail is an excellent addition to our growing and experienced team and will contribute substantial sales management experience and expertise. As a President’s Club top-performer with a consultative approach, Abigail will bring great value to our fast-growing, world-class team.” Nadine went on to share: “Much of our expediential growth is driven by Life Science companies and partners that increasingly choose to work with CSafe as a single-source partner, recognizing our unique ability to problem solve their most complex cold chain challenges with both active and passive cold chain solutions. They understand that we are focused on serving their patients who are receiving critical, life-saving biopharmaceutical, biosimilar and medical device treatments that require the most robust solutions. There is no other global manufacturer with the breadth and depth of cold chain offerings that CSafe brings, which is why on-boarding talented professionals like Abigail, who will leverage her deep industry knowledge to further expand our market growth lead, is so important.”

Strategic Milestone for CSafe Global Cold Chain Biopharmaceutical Solutions Provider

Dayton, OH Aug 9, 2016 – CSafe Global announces a significant strategic growth milestone with the manufacture of the 1000th RKN active container.
This accomplishment is a testament to the dedication of our manufacturing, customer service, technical support and sales team as we continue meet the increasing demand from biopharmaceutical companies for the CSafe RKN. Biologics and vaccines, the most temperature sensitive products to make and transport, dominate the drug treatments developed and commercially available to patients today. These high value biologics require the most robust temperature protection available during transport, resulting in the majority of biopharmaceutical companies increasingly relying upon the CSafe RKN to safeguard their new treatment medicines. We pause to thank the growing number of life science companies and partners that have trusted the superior quality of the CSafe RKN since the production of our first container almost nine years ago.
Life Science companies recognize the CSafe RKN for its efficiency, reliability and continuity of performance. This is due in part to CSafe Global’s industry unique presentative maintenance program which insures every RKN in the CSafe fleet to have the performance equivalent to those that are newly manufactured. CSafe supports customers with online ordering, instant temperature data download, flexible leasing programs including one-way leases, and a large global service network. The CSafe RKN utilizes heating and compressor-driven cooling technology combined with our proprietary ThermoCor® insulation technology. This combination of active and passive technology in one solution, provides the widest range of temperature protection for the longest duration in ambient conditions ranging from -30°C to +49°C.
The RKN is part of CSafe’s comprehensive portfolio of temperature-sensitive transportation solutions that includes active and passive pallet shippers, passive and active small parcel packaging and hand-held courier solutions. The transportation of every biopharmaceutical shipment is a journey that concludes with a patient’s health and safety in mind. There is no margin for error. Drugs must be shipped safely and securely and kept within these tight temperature parameters. The transportation of these biologics often includes long, multi-day journeys which can involve the traversing of hemispheres, continents, and countries. Transfers between multiple modes of transport, huge temperature and climatic variations combined with global training and language barriers all add to the temperature stability risk. CSafe solutions provide the superior cold chain packaging which overcomes these challenges delivering the performance that our customers need while driving cost efficiencies over most existing packaging systems.
To support the growing RKN fleet and the addition of new business entities in France, the Netherlands, Japan, Korea and Puerto Rico, CSafe will add eight new service centre sites to our global network in 2016.
To view the video, visit https://youtu.be/WbFYlu7qsg8